Smoking CessationNCT04909320
Mobile-based Positive Psychological Support for Smoking Cessation Via "Quit to Win" Contest 2021 (QTW 2021)
A study testing AWARD advice, Brief leaflet on health warning and smoking cessation and Referral card in people with Smoking Cessation, run by The University of Hong Kong at 1 site in China.
Trial summary
This study aims to explore the effectiveness of a combined intervention using brief cessation advice and personalized chat-based positive psychological support compared with the control group on current smokers who join the Quit to Win Contest. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Smoking Cessation
- What is being tested?
- AWARD advice, Brief leaflet on health warning and smoking cessation and Referral card
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,094 participants
- Where
- 1 siteChina
- Study dates
- 12 Jun 2021to 30 Jun 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Hong Kong residents aged 18 or above
- Smoke at least 1 tobacco stick (includes HTP) per day or use e-cigarette daily in the past 3-month
- Able to communicate in Chinese
- Saliva cotinine 30 ng/ml or above
- Intent to quit/reduce smoking
- Able to use the instant messaging tool (e.g., WhatsApp, WeChat) for communication
Who cannot join
- Smokers who have communication barrier (either physically or cognitively)
- Smokers who are currently participating in other SC programmes or services
Trial locations and contacts
1 site in 1 country.
China1 site, 1 recruiting
- Recruiting
Hong Kong Council on Smoking and Health (COSH)
Hong Kong, Hong Kong, 852
Fung Wong, +852 2180 5186
Man Ping Kelvin Wang, PhD
About this study
Official title: Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2021: Mobile-based Positive Psychological Support on Smoking Cessation
This study aims to explore the effectiveness of a combined intervention using brief cessation advice and personalized chat-based positive psychological support compared with the control group on current smokers who join the Quit to Win Contest.
Read the detailed description
Smoking is a leading cause of many diseases and deaths globally. Although Hong Kong has a relatively low overall smoking rate of 10.2% (in 2019), health and economic burdens due to smoking are still substantial. The practice of smoking might predispose smokers to COVID-19 infection and poor prognosis. Growing evidence has also suggested that smokers are at higher risk of developing serious respiratory and cardiovascular symptoms in the COVID-19 pandemic than non-smokers. Smoking cessation in the post-COVID-19 era is the key priority to meet the HKSAR Government's target of reducing smoking prevalence to 7.8% by 2025.
Mental health problems are commonly comorbid with smoking and related problems. Our population-based survey amidst the COVID-19 pandemic found current smokers were at higher risk of suffering from anxious symptoms (adjusted OR 1.84 95% CI 1.27, 2.67), depressive symptoms (adjusted OR 2.04 95% CI 1.40, 2.96), and stress symptoms (adjusted β 0.54 95% CI 0.26, 0.82) compared with non-smokers. We also observed mental health burden increased during the COVID-19 pandemic with approximately doubling of the prevalence of anxious symptoms (15.8 vs. 9.3) and depressive symptoms (14.8 vs. 6.3) compared with the pre-COVID-19 pandemic (2017). Mental health can be both precursors and consequences of smoking. Previous studies have suggested that depressive symptoms and low positive affect during and after SC attempts are associated with poor cessation outcomes. This implies that a combined intervention of behavioral and psychological SC intervention is needed, particularly under the circumstance of worsening mental health problems.
Therefore, our study aims to test the effectiveness of a combined intervention using brief cessation advice and personalized chat-based positive psychological support compared with the control group on current smokers who join the Quit to Win Contest.
- Conditions
- Smoking Cessation
- Being tested
- AWARD advice, Brief leaflet on health warning and smoking cessation, Referral card, Self-help smoking cessation booklet, Positive psychological support through 3-people group chat using instant messaging apps
- Keywords
- smoking cessation, positive psychological support, mobile health, peer supporter
- Medical subject headings
- Smoking Cessation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AWARD adviceBehavioural
Ask about smoking history; Warn about the high risk; Advise to quit; Refer smokers to smoking cessation services (with a referral card); Do it again
Brief leaflet on health warning and smoking cessationOther
The contents of the leaflet include (1) highlights of the absolute risk of death due to smoking; (2) the whole list of diseases caused by active and second-hand smoking; (3) ten horrible pictorial warnings of health consequences of smoking and second-hand smoking in one page to maximize the impacts; (4) benefits of SC and (5) simple messages to encourage participants to quit smoking and remind them to call the Department of Health SC hotline 183 3183.
Referral cardOther
The contents consist of brief information and highlights of existing SC services, contact methods, motivation information, and strong supporting messages or slogans.
Self-help smoking cessation bookletOther
The contents include information about the benefits of quitting, smoking and diseases, methods to quit, how to handle withdrawal symptoms, declaration of quitting, etc.
Positive psychological support through 3-people group chat using instant messaging appsBehavioural
Each IM chat group will consist of a trained SC counselor (HKU staff), a peer supporter (former smoker), and a participant (smoker). The 3-month group chat-based intervention will consist of regular messages and real-time support through group chat. Regular messages will generally include goal setting, health warnings, abstinence support, positive psychological exercises, and encouragement and will be delivered in a tapering style. During the real-time chatting, SC counsellors and peer supporters will provide real-time chat-based support, and peer supporters will share their quitting experience as appropriate.
E-messages via SMSBehavioural
Regular e-messages via SMS at twice per month within 3 months (total 6).
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | Not described Receives: Behavioral: AWARD advice; Other: Brief leaflet on health warning and smoking cessation; Other: Referral card; Other: Self-help smoking cessation booklet; Behavioral: Positive psychological support through 3-people group chat using instant messaging apps |
| Control group | Active comparator | Not described Receives: Behavioral: AWARD advice; Other: Brief leaflet on health warning and smoking cessation; Other: Referral card; Other: Self-help smoking cessation booklet; Behavioral: E-messages via SMS |
What is being measured
The primary outcome is the main question the study is designed to answer.
Biochemically validated abstinence
Defined as exhaled CO level <4ppm and saliva cotinine level ≤30 ng/ml
Note
- If participants refuse to have a face-to-face exhaled carbon monoxide test due to the COVID-19 pandemic in Hong Kong. In that case, the outcome will only be validated by a saliva cotinine test device.
- If participants use NRT, the outcome will be validated by exhaled carbon monoxide only.
Measured: 6-month follow-up
Secondary outcomes (31)
Biochemically validated abstinence
Defined as exhaled CO level <4ppm and saliva cotinine level ≤30 ng/ml
Note
- If participants refuse to have a face-to-face exhaled carbon monoxide test due to the COVID-19 pandemic in Hong Kong. In that case, the outcome will only be validated by a saliva cotinine test device.
- If participants use NRT, the outcome will be validated by exhaled carbon monoxide only.
Measured: 3-month follow-up
Self-reported 7-day point prevalence quit rate
Smokers who did not smoke even a puff in the 7 days preceding the follow-up
Measured: 3-month follow-up
Self-reported 7-day point prevalence quit rate
Smokers who did not smoke even a puff in the 7 days preceding the follow-up
Measured: 6-month follow-up
Self-reported reduction
Defined by at least 50% reduction in baseline daily number of cigarettes
Measured: 3-month follow-up
Self-reported reduction
Defined by at least 50% reduction in baseline daily number of cigarettes
Measured: 6-month follow-up
Self-reported depressive symptoms
Measured by Patient Health Questionnaire-2 (PHQ-2). PHQ-2 ranges from 0-6, a higher score indicates a severer depressive symptom.
Measured: 3-month follow-up
Self-reported depressive symptoms
Measured by Patient Health Questionnaire-2 (PHQ-2). PHQ-2 ranges from 0-6, a higher score indicates a severer depressive symptom.
Measured: 6-month follow-up
Self-reported anxious symptoms
Measured by Generalized Anxiety Disorder-2 (GAD-2). GAD-2 ranges from 0-6, a higher score indicates a severer anxious symptom.
Measured: 6-month follow-up
Self-reported anxious symptoms
Measured by Generalized Anxiety Disorder-2 (GAD-2). GAD-2 ranges from 0-6, a higher score indicates a severer anxious symptom.
Measured: 3-month follow-up
Self-reported use of smoking cessation service
Use of smoking cessation service at 3- and 6- month follow-up
Measured: 3-month follow-up
Self-reported use of smoking cessation service
Use of smoking cessation service at 3- and 6- month follow-up
Measured: 6-month follow-up
Self-rated health
Self-rated health will be measured as a single item with the response items "excellent", "very good", "good", "fair", or "poor".
Measured: 3-month follow-up
Self-rated health
Self-rated health will be measured as a single item with the response items "excellent", "very good", "good", "fair", or "poor".
Measured: 6-month follow-up
Self-reported happiness
A single item will measure self-reported happiness with an answer on an 11-point scale (0-10). A higher score indicates a higher level of happiness.
Measured: 3-month follow-up
Self-reported happiness
A single item will measure self-reported happiness with an answer on an 11-point scale (0-10). A higher score indicates a higher level of happiness.
Measured: 6-month follow-up
Self-reported quit attempts
Number of quit attempts from baseline at 3-month follow-up
Measured: 3-month follow-up
Self-reported quit attempts
Number of quit attempts from baseline at 6-month follow-up
Measured: 6-month follow-up
Self-reported resilience
A single item will measure self-reported resilience with an answer on an 11-point scale (0-10). A higher score indicates a higher level of resilience.
Measured: 3-month follow-up
Self-reported resilience
A single item will measure self-reported resilience with an answer on an 11-point scale (0-10). A higher score indicates a higher level of resilience.
Measured: 6-month follow-up
Self-reported optimistic
A single item will measure self-reported optimistic with an answer on an 11-point scale (0-10). A higher score indicates a higher level of optimistic.
Measured: 3-month follow-up
Self-reported optimistic
A single item will measure self-reported optimistic with an answer on an 11-point scale (0-10). A higher score indicates a higher level of optimistic.
Measured: 6-month follow-up
Self-reported loneliness
A single item will measure self-reported loneliness with an answer on an 11-point scale (0-10). A higher score indicates a higher level of loneliness.
Measured: 3-month follow-up
Self-reported loneliness
A single item will measure self-reported loneliness with an answer on an 11-point scale (0-10). A higher score indicates a higher level of loneliness.
Measured: 6-month follow-up
Self-reported stress
A single item will measure self-reported stress with an answer on an 11-point scale (0-10). A higher score indicates a higher level of stress.
Measured: 6-month follow-up
Self-reported stress
A single item will measure self-reported stress with an answer on an 11-point scale (0-10). A higher score indicates a higher level of stress.
Measured: 3-month follow-up
Self-reported social support
A single item will measure self-reported social support with an answer on an 11-point scale (0-10). A higher score indicates a higher level of social support.
Measured: 3-month follow-up
Self-reported social support
A single item will measure self-reported social support with an answer on an 11-point scale (0-10). A higher score indicates a higher level of social support.
Measured: 6-month follow-up
Self-reported positive affect
The subscale of the Chinese version International Positive and Negative Affect Schedule Short Form (I-PANAS-SF) will measure self-reported positive affect. The I-PANAS-SF uses a 5-point scale, a higher score indicates a higher level of self-reported positive affect.
Measured: 3-month follow-up
Self-reported positive affect
The subscale of the Chinese version International Positive and Negative Affect Schedule Short Form (I-PANAS-SF) will measure self-reported positive affect. The I-PANAS-SF uses a 5-point scale, a higher score indicates a higher level of self-reported positive affect.
Measured: 6-month follow-up
Self-reported negative affect
The subscale of the Chinese version International Positive and Negative Affect Schedule Short Form (I-PANAS-SF) will measure self-reported negative affect. The I-PANAS-SF uses a 5-point scale, a higher score indicates a higher level of self-reported negative affect.
Measured: 6-month follow-up
Self-reported negative affect
The subscale of the Chinese version International Positive and Negative Affect Schedule Short Form (I-PANAS-SF) will measure self-reported negative affect. The I-PANAS-SF uses a 5-point scale, a higher score indicates a higher level of self-reported negative affect.
Measured: 3-month follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jun 2021
- Study start12 Jun 2021
- Primary completion30 Jun 2022
- Study completion30 Jun 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Smoking CessationStudies of the same condition, open and under way.
- More trials run by The University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 1,094 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The University of Hong Kong
- Sponsor type
- University, hospital or other
- Collaborators
- Hong Kong Council on Smoking and Health
- Responsible party
- Principal investigator, Dr. Wang Man-Ping, The University of Hong Kong
- Investigators
- Man Ping Wang, PhD, Principal investigator, The University of Hong Kong
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04909320
- Sponsor's protocol ID
- QTW 2021
- Status last verified
- Aug 2022
- First submitted
- 26 May 2021
- Last updated
- 17 Aug 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Zeng Y, Wu YS, Luk TT, Zhao SZ, Guo Z, Li Y, Tong HSC, Lai VWY, Cheung YTD, Lam TH, Wang MP. Quitting trajectories of Hong Kong Chinese smokers receiving behavioral smoking cessation interventions: A post hoc analysis of eight randomized controlled trials. Addiction. 2026 Jun;121(6):1568-1579. doi: 10.1111/add.70328. Epub 2026 Jan 17.
PubMed 41546550Guo Z, Luk TT, Weng X, Wu Y, Zhao S, Lai YK, Cheung DYT, Tong HSC, Lai VWY, Lam TH, Wang MP. Behavioral Support by Ex-Smoking Peers Using Instant Messaging for Smoking Cessation: A Randomized Controlled Trial. Chest. 2026 Jan;169(1):300-311. doi: 10.1016/j.chest.2025.07.4110. Epub 2025 Sep 10.
PubMed 40939935
Study at a glance
From the registry record, last updated by the sponsor on 17 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Building Capacity and Promoting Smoking Cessation in the Community Via "Quit to Win" Contest 2021: Mobile-based Positive Psychological Support on Smoking Cessation
- ClinicalTrials.gov ID
- NCT04909320
- Acronym / sponsor ID
- QTW 2021
- Conditions
- Smoking Cessation
- Keywords
- smoking cessation, positive psychological support, mobile health, peer supporter
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 1,094 participants (estimated)
- Lead sponsor
- The University of Hong KongUniversity, hospital or other
- Collaborators
- Hong Kong Council on Smoking and Health
- Study start
- 12 Jun 2021 (actual)
- Primary completion
- 30 Jun 2022 (actual)
- Study completion
- 30 Jun 2023 (estimated)
- First posted
- 1 Jun 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to explore the effectiveness of a combined intervention using brief cessation advice and personalized chat-based positive psychological support compared with the control group on current smokers who join the Quit to Win Contest.
Detailed description
Smoking is a leading cause of many diseases and deaths globally. Although Hong Kong has a relatively low overall smoking rate of 10.2% (in 2019), health and economic burdens due to smoking are still substantial. The practice of smoking might predispose smokers to COVID-19 infection and poor prognosis. Growing evidence has also suggested that smokers are at higher risk of developing serious respiratory and cardiovascular symptoms in the COVID-19 pandemic than non-smokers. Smoking cessation in the post-COVID-19 era is the key priority to meet the HKSAR Government's target of reducing smoking prevalence to 7.8% by 2025.
Mental health problems are commonly comorbid with smoking and related problems. Our population-based survey amidst the COVID-19 pandemic found current smokers were at higher risk of suffering from anxious symptoms (adjusted OR 1.84 95% CI 1.27, 2.67), depressive symptoms (adjusted OR 2.04 95% CI 1.40, 2.96), and stress symptoms (adjusted β 0.54 95% CI 0.26, 0.82) compared with non-smokers. We also observed mental health burden increased during the COVID-19 pandemic with approximately doubling of the prevalence of anxious symptoms (15.8 vs. 9.3) and depressive symptoms (14.8 vs. 6.3) compared with the pre-COVID-19 pandemic (2017). Mental health can be both precursors and consequences of smoking. Previous studies have suggested that depressive symptoms and low positive affect during and after SC attempts are associated with poor cessation outcomes. This implies that a combined intervention of behavioral and psychological SC intervention is needed, particularly under the circumstance of worsening mental health problems.
Therefore, our study aims to test the effectiveness of a combined intervention using brief cessation advice and personalized chat-based positive psychological support compared with the control group on current smokers who join the Quit to Win Contest.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Behavioral: AWARD advice, Other: Brief leaflet on health warning and smoking cessation, Other: Referral card, Other: Self-help smoking cessation booklet, Behavioral: Positive psychological support through 3-people group chat using instant messaging apps |
| Control group | Active comparator | Behavioral: AWARD advice, Other: Brief leaflet on health warning and smoking cessation, Other: Referral card, Other: Self-help smoking cessation booklet, Behavioral: E-messages via SMS |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Hong Kong residents aged 18 or above
- Smoke at least 1 tobacco stick (includes HTP) per day or use e-cigarette daily in the past 3-month
- Able to communicate in Chinese
- Saliva cotinine 30 ng/ml or above
- Intent to quit/reduce smoking
Key exclusion criteria (2 listed)
- Smokers who have communication barrier (either physically or cognitively)
- Smokers who are currently participating in other SC programmes or services
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AWARD adviceAsk about smoking history; Warn about the high risk; Advise to quit; Refer smokers to smoking cessation services (with a referral card); Do it again | Behavioural | Control group, Intervention group |
| Brief leaflet on health warning and smoking cessationThe contents of the leaflet include (1) highlights of the absolute risk of death due to smoking; (2) the whole list of diseases caused by active and second-hand smoking; (3) ten horrible pictorial warnings of health consequences of smoking and second-hand smoking in one page to maximize the impacts; (4) benefits of SC and (5) simple messages to encourage participants to quit smoking and remind them to call the Department of Health SC hotline 183 3183. | Other | Control group, Intervention group |
| Referral cardThe contents consist of brief information and highlights of existing SC services, contact methods, motivation information, and strong supporting messages or slogans. | Other | Control group, Intervention group |
| Self-help smoking cessation bookletThe contents include information about the benefits of quitting, smoking and diseases, methods to quit, how to handle withdrawal symptoms, declaration of quitting, etc. | Other | Control group, Intervention group |
| Positive psychological support through 3-people group chat using instant messaging appsEach IM chat group will consist of a trained SC counselor (HKU staff), a peer supporter (former smoker), and a participant (smoker). The 3-month group chat-based intervention will consist of regular messages and real-time support through group chat. Regular messages will generally include goal setting, health warnings, abstinence support, positive psychological exercises, and encouragement and will be delivered in a tapering style. During the real-time chatting, SC counsellors and peer supporters will provide real-time chat-based support, and peer supporters will share their quitting experience as appropriate. | Behavioural | Intervention group |
| E-messages via SMSRegular e-messages via SMS at twice per month within 3 months (total 6). | Behavioural | Control group |
Primary outcome
Biochemically validated abstinence
Time frame: 6-month follow-up
Defined as exhaled CO level <4ppm and saliva cotinine level ≤30 ng/ml Note 1. If participants refuse to have a face-to-face exhaled carbon monoxide test due to the COVID-19 pandemic in Hong Kong. In that case, the outcome will only be validated by a saliva cotinine test device. 2. If participants use NRT, the outcome will be validated by exhaled carbon monoxide only.
31 secondary outcomes
Biochemically validated abstinence
Time frame: 3-month follow-up
Self-reported 7-day point prevalence quit rate
Time frame: 3-month follow-up
Self-reported 7-day point prevalence quit rate
Time frame: 6-month follow-up
Self-reported reduction
Time frame: 3-month follow-up
Self-reported reduction
Time frame: 6-month follow-up
Self-reported depressive symptoms
Time frame: 3-month follow-up
Self-reported depressive symptoms
Time frame: 6-month follow-up
Self-reported anxious symptoms
Time frame: 6-month follow-up
Self-reported anxious symptoms
Time frame: 3-month follow-up
Self-reported use of smoking cessation service
Time frame: 3-month follow-up
Self-reported use of smoking cessation service
Time frame: 6-month follow-up
Self-rated health
Time frame: 3-month follow-up
Self-rated health
Time frame: 6-month follow-up
Self-reported happiness
Time frame: 3-month follow-up
Self-reported happiness
Time frame: 6-month follow-up
Self-reported quit attempts
Time frame: 3-month follow-up
Self-reported quit attempts
Time frame: 6-month follow-up
Self-reported resilience
Time frame: 3-month follow-up
Self-reported resilience
Time frame: 6-month follow-up
Self-reported optimistic
Time frame: 3-month follow-up
Self-reported optimistic
Time frame: 6-month follow-up
Self-reported loneliness
Time frame: 3-month follow-up
Self-reported loneliness
Time frame: 6-month follow-up
Self-reported stress
Time frame: 6-month follow-up
Self-reported stress
Time frame: 3-month follow-up
Self-reported social support
Time frame: 3-month follow-up
Self-reported social support
Time frame: 6-month follow-up
Self-reported positive affect
Time frame: 3-month follow-up
Self-reported positive affect
Time frame: 6-month follow-up
Self-reported negative affect
Time frame: 6-month follow-up
Self-reported negative affect
Time frame: 3-month follow-up
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Aug 2022.
- Derived from this study: PubMed 41546550Zeng Y, Wu YS, Luk TT, Zhao SZ, Guo Z, Li Y, Tong HSC, Lai VWY, Cheung YTD, Lam TH, Wang MP. Quitting trajectories of Hong Kong Chinese smokers receiving behavioral smoking cessation interventions: A post hoc analysis of eight randomized controlled trials. Addiction. 2026 Jun;121(6):1568-1579. doi: 10.1111/add.70328. Epub 2026 Jan 17.
- Derived from this study: PubMed 40939935Guo Z, Luk TT, Weng X, Wu Y, Zhao S, Lai YK, Cheung DYT, Tong HSC, Lai VWY, Lam TH, Wang MP. Behavioral Support by Ex-Smoking Peers Using Instant Messaging for Smoking Cessation: A Randomized Controlled Trial. Chest. 2026 Jan;169(1):300-311. doi: 10.1016/j.chest.2025.07.4110. Epub 2025 Sep 10.
- Individual participant dataSharing planned: No
Related trials for Smoking Cessation
Enrolling by invitationObservational study
Using Smartwatches to Monitor Smoking in Real-life Situations
Smoking
Not yet recruiting
Comparing the Efficacy of a Conversational Agent (QuitBot) Versus Standard Health Education on Smoking Cessation Among Medical Students in Cairo University
Conversational Agent, Smoking Cessation
RecruitingObservational study
§SMOKE Nicotine and Tobacco Youth Cohort
Tobacco Use Behavior, Nicotine Dependence Tobacco Product
Active, not recruitingEarly Phase 1
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
Smoking Cessation
Active, not recruitingPhase 3
Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
Tobacco Dependence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Man Ping Wang, PhD principal investigator
The University of Hong Kong
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing AWARD advice, Brief leaflet on health warning and smoking cessation and Referral card in people with Smoking Cessation, run by The University of Hong Kong at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 17 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Man Ping Wang, PhD (+852 3917 6636, mpwang@hku.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Biochemically validated abstinence (time frame: 6-month follow-up). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04909320, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2022.